全文获取类型
收费全文 | 1835604篇 |
免费 | 141530篇 |
国内免费 | 3777篇 |
专业分类
耳鼻咽喉 | 24372篇 |
儿科学 | 60349篇 |
妇产科学 | 51970篇 |
基础医学 | 271988篇 |
口腔科学 | 50346篇 |
临床医学 | 164101篇 |
内科学 | 358374篇 |
皮肤病学 | 43042篇 |
神经病学 | 145816篇 |
特种医学 | 68982篇 |
外国民族医学 | 523篇 |
外科学 | 274869篇 |
综合类 | 39793篇 |
现状与发展 | 3篇 |
一般理论 | 604篇 |
预防医学 | 143798篇 |
眼科学 | 41899篇 |
药学 | 133216篇 |
1篇 | |
中国医学 | 4126篇 |
肿瘤学 | 102739篇 |
出版年
2018年 | 20276篇 |
2017年 | 15380篇 |
2016年 | 17373篇 |
2015年 | 19421篇 |
2014年 | 27254篇 |
2013年 | 40872篇 |
2012年 | 55547篇 |
2011年 | 59262篇 |
2010年 | 34787篇 |
2009年 | 33158篇 |
2008年 | 55113篇 |
2007年 | 58609篇 |
2006年 | 59347篇 |
2005年 | 57364篇 |
2004年 | 55092篇 |
2003年 | 52551篇 |
2002年 | 51016篇 |
2001年 | 91056篇 |
2000年 | 93313篇 |
1999年 | 77239篇 |
1998年 | 21343篇 |
1997年 | 19112篇 |
1996年 | 19426篇 |
1995年 | 18370篇 |
1994年 | 16789篇 |
1993年 | 15843篇 |
1992年 | 58532篇 |
1991年 | 56954篇 |
1990年 | 55286篇 |
1989年 | 52869篇 |
1988年 | 48532篇 |
1987年 | 47654篇 |
1986年 | 44539篇 |
1985年 | 42534篇 |
1984年 | 32211篇 |
1983年 | 27173篇 |
1982年 | 16083篇 |
1981年 | 14424篇 |
1979年 | 28993篇 |
1978年 | 20657篇 |
1977年 | 17204篇 |
1976年 | 16427篇 |
1975年 | 17445篇 |
1974年 | 21013篇 |
1973年 | 20051篇 |
1972年 | 18997篇 |
1971年 | 17649篇 |
1970年 | 16544篇 |
1969年 | 15573篇 |
1968年 | 14745篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
103.
104.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study 下载免费PDF全文
105.
E. M. Peterman C. Sullivan M. F. Goody I. Rodriguez-Nunez J. A. Yoder C. H. Kim 《Infection and immunity》2015,83(1):430-440
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections. 相似文献
106.
107.
108.
109.
110.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献